Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001176256-09-000985
Filing Date
2009-11-06
Accepted
2009-11-05 21:01:25
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008 - AMENDMENT NO. 2 angiotech10kadec.htm 10-K/A 1469854
2 DISCLOSURE INCORPORATED BY REFERENCE INTO PART II OF THIS ANNUAL REPORT ON FORM exhibit13.htm EX-13 1018815
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP exhibit23-1.htm EX-23.1 1836
4 SECTION 302 CEO CERTIFICATION exhibit31-1.htm EX-31.1 7768
5 SECTION 302 CFO CERTIFICATION exhibit31-2.htm EX-31.2 7786
6 SECTION 906 CEO AND CFO CERTIFICATION exhibit32-1.htm EX-32.1 4588
  Complete submission text file 0001176256-09-000985.txt   2511976
Mailing Address
Business Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
ANGIOTECH PHARMACEUTICALS INC (Filer) CIK: 0001096481 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30334 | Film No.: 091162595
SIC: 3841 Surgical & Medical Instruments & Apparatus